Mast cell tumors (MCTs) are among the most common skin cancers affecting dogs and cats. These tumors originate from mast ...

Celldex Therapeutics, Inc. has rallied over 70% off April 2025 lows, driven by optimism for lead candidate barzolvolimab in ...

Pre-clinical data supports ECRIs' broad-spectrum attack on the IgE axis, distinct from conventional anti-IgE therapies, ...

Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of ...

The allergic rhino-conjunctivitis market is experiencing steady growth, driven by the rising prevalence of allergic ...

The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for ...

Bristol Myers Squibb is buying startup Orbital Therapeutics for $1.5 billion, aiming to develop more scalable cell therapies ...

Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of ...

An NHS GP spotlighted a 'massively underdiagnosed' condition that can trigger numerous common symptoms, including ...

An NHS GP has shed light on a little-known but 'massively underdiagnosed' condition that can cause several common symptoms, ...

Lipomas are the most common benign skin tumors of dogs, which are most frequently found in middle-aged and overweight animals ...

The main types of allergy eye drops are antihistamines, mast cell stabilizers, and non-steroidal anti-inflammatory drugs.